Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Short-term Investments (2024 - 2025)

Praxis Precision Medicines has reported Short-term Investments over the past 2 years, most recently at $242.0 million for Q4 2025.

  • Quarterly results put Short-term Investments at $242.0 million for Q4 2025, up 36.57% from a year ago — trailing twelve months through Dec 2025 was $242.0 million (up 36.57% YoY), and the annual figure for FY2025 was $242.0 million, up 36.57%.
  • Short-term Investments for Q4 2025 was $242.0 million at Praxis Precision Medicines, up from $117.6 million in the prior quarter.
  • Over the last five years, Short-term Investments for PRAX hit a ceiling of $242.0 million in Q4 2025 and a floor of $55.4 million in Q1 2024.